NASDAQ:SKIN
The Beauty Health Company
- Stock
Last Close
1.39
22/11 21:00
Market Cap
217.59M
Beta: 1.13
Volume Today
497.07K
Avg: 1.90M
PE Ratio
−4.40
PFCF: 36.08
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -317K - | -1.64M 416.72% | -29.18M 1,681.14% | -375.11M 1,185.72% | 44.38M 111.83% | -100.12M 325.57% | |
depreciation and amortization | 11.50M - | 13.88M 20.75% | 14.40M 3.75% | 21.14M 46.76% | 22.02M 4.17% | 32.24M 46.43% | |
deferred income tax | -3.02M - | -4.65M 54.20% | -4.34M 6.63% | -3.76M 13.31% | -1.79M 52.51% | -51.87M 2,802.69% | |
stock based compensation | 61K - | 103K 68.85% | 363K 252.43% | 12.42M 3,320.94% | 28.50M 129.47% | 22.54M 20.88% | |
change in working capital | -9.78M - | -7.91M 19.10% | -2.58M 67.37% | -18.66M 622.85% | -140.28M 651.62% | 23.36M 116.65% | |
accounts receivables | -7.72M - | -11.05M 43.13% | 3.70M 133.50% | -31.01M 937.96% | -32.02M 3.26% | 12.85M 140.14% | |
inventory | -9.80M - | -4.77M 51.33% | -3.21M 32.67% | -9.44M 194.08% | -82.10M 769.40% | -22.62M 72.45% | |
accounts payables | 4.18M - | 4.31M 3.18% | 4.89M 13.41% | 10.52M 115.24% | 1.61M 84.74% | 15.78M 882.75% | |
other working capital | 3.56M - | 3.59M 0.96% | -7.96M 321.51% | 11.27M 241.55% | -27.77M 346.40% | 17.34M 162.43% | |
other non cash items | 660K - | 1.94M 194.39% | 8.90M 357.95% | 335.62M 3,671.87% | -59.42M 117.71% | 95.60M 260.87% | |
net cash provided by operating activities | -895K - | 1.73M 293.07% | -12.44M 819.68% | -28.36M 128.06% | -106.60M 275.87% | 21.75M 120.40% | |
investments in property plant and equipment | -7.88M - | -10.42M 32.18% | -3.82M 63.38% | -15.62M 309.12% | -17.39M 11.39% | -13.05M 24.98% | |
acquisitions net | -2.06M - | -22.90M - | -1.48M 93.56% | -18.46M 1,151.39% | |||
purchases of investments | |||||||
sales maturities of investments | |||||||
other investing activites | -558K - | 781K - | |||||
net cash used for investing activites | -8.44M - | -12.48M 47.81% | -3.82M 69.42% | -37.73M 888.50% | -18.87M 49.99% | -31.51M 66.98% | |
debt repayment | -5.03M - | -12M 138.66% | -16.77M 39.77% | -230.49M 1,274.23% | |||
common stock issued | -323K - | 938.38M 290,619.50% | 500K 99.95% | -5.47M 1,194.80% | |||
common stock repurchased | -154K - | -160M - | -30.16M 81.15% | ||||
dividends paid | -98.71M - | -323K - | |||||
other financing activites | 114.90M - | 26.58M 76.87% | 35.84M 34.87% | 251.14M 600.64% | -45.74M 118.21% | -1.82M 96.02% | |
net cash used provided by financing activities | 11.16M - | 14.58M 30.58% | 18.27M 25.35% | 959.03M 5,148.37% | -205.24M 121.40% | -37.45M 81.75% | |
effect of forex changes on cash | -3K - | -94K 3,033.33% | 159K 269.15% | -543K 441.51% | -2.98M 448.43% | 2.03M 168.27% | |
net change in cash | 1.82M - | 3.73M 104.72% | 2.18M 41.61% | 892.40M 40,854.57% | -333.69M 137.39% | -45.17M 86.46% | |
cash at beginning of period | 1.75M - | 3.58M 104.05% | 7.31M 104.39% | 9.49M 29.82% | 901.89M 9,407.55% | 568.20M 37.00% | |
cash at end of period | 3.58M - | 7.31M 104.39% | 9.49M 29.82% | 901.89M 9,407.55% | 568.20M 37.00% | 523.02M 7.95% | |
operating cash flow | -895K - | 1.73M 293.07% | -12.44M 819.68% | -28.36M 128.06% | -106.60M 275.87% | 21.75M 120.40% | |
capital expenditure | -7.88M - | -10.42M 32.18% | -3.82M 63.38% | -15.62M 309.12% | -17.39M 11.39% | -13.05M 24.98% | |
free cash flow | -8.78M - | -8.69M 0.98% | -16.25M 86.95% | -43.98M 170.58% | -123.99M 181.95% | 8.70M 107.02% |
All numbers in USD (except ratios and percentages)